 RTT News | Teva Wins FDA Approval For Qnasl Nasal Aerosol To Treat Allergic Rhinitis RTT News Intra-nasal corticosteroids are recommended as first-line therapy for allergic rhinitis and the only available option on the market before the approval of Qnasl (beclomethasone dipropionate) were aqueous formulations. The product is expected to be ... Teva Announces FDA Approval of QNASL(TM)(beclomethasone dipropionate), a New ... |
